These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22851409)

  • 1. Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast-enhanced magnetic resonance images.
    Bahl G; Cruite I; Wolfson T; Gamst AC; Collins JM; Chavez AD; Barakat F; Hassanein T; Sirlin CB
    J Magn Reson Imaging; 2012 Nov; 36(5):1154-61. PubMed ID: 22851409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T.
    Yokoo T; Wolfson T; Iwaisako K; Peterson MR; Mani H; Goodman Z; Changchien C; Middleton MS; Gamst AC; Mazhar SM; Kono Y; Ho SB; Sirlin CB
    Biomed Res Int; 2015; 2015():387653. PubMed ID: 26421287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.
    Aguirre DA; Behling CA; Alpert E; Hassanein TI; Sirlin CB
    Radiology; 2006 May; 239(2):425-37. PubMed ID: 16641352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective staging of fibrosis by the selected texture features of liver: Which one is better, CT or MR imaging?
    Zhang X; Gao X; Liu BJ; Ma K; Yan W; Liling L; Yuhong H; Fujita H
    Comput Med Imaging Graph; 2015 Dec; 46 Pt 2():227-36. PubMed ID: 26455963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C related chronic liver cirrhosis: feasibility of texture analysis of MR images for classification of fibrosis stage and necroinflammatory activity grade.
    Wu Z; Matsui O; Kitao A; Kozaka K; Koda W; Kobayashi S; Ryu Y; Minami T; Sanada J; Gabata T
    PLoS One; 2015; 10(3):e0118297. PubMed ID: 25742285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
    J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study.
    Smits LP; Coolen BF; Panno MD; Runge JH; Nijhof WH; Verheij J; Nieuwdorp M; Stoker J; Beuers UH; Nederveen AJ; Stroes ES
    Radiology; 2016 Mar; 278(3):782-91. PubMed ID: 26348104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of texture analysis on parametric T
    Yu H; Touret AS; Li B; O'Brien M; Qureshi MM; Soto JA; Jara H; Anderson SW
    J Magn Reson Imaging; 2017 Jan; 45(1):250-259. PubMed ID: 27249625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
    Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
    J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging.
    Hako R; Kristian P; Jarčuška P; Haková I; Hockicková I; Schréter I; Janičko M
    Can J Gastroenterol Hepatol; 2019; 2019():3024630. PubMed ID: 31058108
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver dynamic contrast-enhanced MRI for staging liver fibrosis in a piglet model.
    Zhou L; Chen TW; Zhang XM; Yang Z; Tang HJ; Deng D; Zeng NL; Wang LY; Chen XL; Li H; Li CP; Li L; Xie XY; Hu J
    J Magn Reson Imaging; 2014 Apr; 39(4):872-8. PubMed ID: 24123400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of texture analysis for quantifying hepatic fibrosis on proton density MRI.
    Yu H; Buch K; Li B; O'Brien M; Soto J; Jara H; Anderson SW
    J Magn Reson Imaging; 2015 Nov; 42(5):1259-65. PubMed ID: 26477447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using texture analyses of contrast enhanced CT to assess hepatic fibrosis.
    Daginawala N; Li B; Buch K; Yu H; Tischler B; Qureshi MM; Soto JA; Anderson S
    Eur J Radiol; 2016 Mar; 85(3):511-7. PubMed ID: 26860661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer molecular subtype classifier that incorporates MRI features.
    Sutton EJ; Dashevsky BZ; Oh JH; Veeraraghavan H; Apte AP; Thakur SB; Morris EA; Deasy JO
    J Magn Reson Imaging; 2016 Jul; 44(1):122-9. PubMed ID: 26756416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Texture-based classification of liver fibrosis using MRI.
    House MJ; Bangma SJ; Thomas M; Gan EK; Ayonrinde OT; Adams LA; Olynyk JK; St Pierre TG
    J Magn Reson Imaging; 2015 Feb; 41(2):322-8. PubMed ID: 24347292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.
    Tsuda N; Okada M; Murakami T
    Eur J Radiol; 2010 Jan; 73(1):137-42. PubMed ID: 19026502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA.
    Nishie A; Asayama Y; Ishigami K; Tajima T; Kakihara D; Nakayama T; Takayama Y; Okamoto D; Taketomi A; Shirabe K; Fujita N; Obara M; Yoshimitsu K; Honda H
    J Magn Reson Imaging; 2012 Sep; 36(3):664-71. PubMed ID: 22532503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI for characterization of primary tumors in the non-cirrhotic liver: added value of Gd-EOB-DTPA enhanced hepatospecific phase.
    Donati OF; Hunziker R; Fischer MA; Raptis DA; Breitenstein S; Patak MA
    Eur J Radiol; 2014 Jul; 83(7):1074-1079. PubMed ID: 24816085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.